Author/Creator: Blauvelt, A. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Blauvelt, A.

111. 有多少人开发生物制剂 tildrakizumab 的抗药抗体, 以及这对其治疗有效性产生哪些影响. (2nd January 2020)

Authors:: Kimball, A.B.; Kerbusch, T.; van Aarle, F.; Kulkarni, P.; Li, Q.; Blauvelt, A.; Papp, K.A.; Reich, K.; Montgomery, D.
Journal:: British journal of dermatology
Issue:: Volume 182:Number 1(2020)
Page Start:: e48
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

112. 生物药物 ixekizumab 和 guselkumab 治疗中度至重度斑块型银屑病的比较研究. (1st June 2020)

Authors:: Blauvelt, A.; Papp, K.; Gottlieb, A.; Jarell, A.; Reich, K.; Maari, C.; Gordon, K.B.; Ferris, L.K.; Langley, R.G.; Tada, Y.; Lima, R.G.; Elmaraghy, H.; Gallo, G.; Renda, L.; Park, S.Y.; Burge, R.; Bagel, J.
Journal:: British journal of dermatology
Issue:: Volume 182:Number 6(2020)
Page Start:: e205
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

113. 药物 Tildrakizumab 治疗斑块型银屑病的研究. (1st June 2020)

Authors:: Kimball, A.B.; Papp, K.A.; Reich, K.; Gooderham, M.; Li, Q.; Cichanowitz, N.; La Rosa, C.; Blauvelt, A.
Journal:: British journal of dermatology
Issue:: Volume 182:Number 6(2020)
Page Start:: e208
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

114. 评估接受 Dupilumab 治疗的中度至重度特应性皮炎患者进行常规安全性检测的必要性. (1st June 2020)

Authors:: Wollenberg, A.; Beck, L.A.; Blauvelt, A.; Simpson, E.L.; Chen, Z.; Chen, Q.; Shumel, B.; Khokhar, F.A.; Hultsch, T.; Rizova, E.; Rossi, A.B.; Graham, N.M.H.; Pirozzi, G.; Lu, Y.; Ardeleanu, M.
Journal:: British journal of dermatology
Issue:: Volume 182:Number 6(2020)
Page Start:: e198
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗